Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| (NASDAQ: PXS) | Delayed: 7.39 +0.25 (3.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.14 | 52 Week High | $4.27 | |||
| Open | $7.34 | 52 Week Low | $0.55 | |||
| Day High | $7.50 | P/E | N/A | |||
| Day Low | $7.18 | EPS | $0.00 | |||
| Volume | 80,633 | |||||
